STACK SCIENCEHomeShopResearchLearnSignal LibrarySignal IQCalculatorSkoolCoA LibraryAboutFAQsContact0Shop NowHomeShopResearchLearnSignal LibrarySignal IQCalculatorSkoolCoA LibraryAboutFAQsContactAccountMy Account
SKU: SS-ADAMAX Categories: ,

ADAMAX

In Stock

$150.00

Verified Test Results

Every batch, independently verified.

Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory before it ships. This is the released report for the current batch, exactly as the lab signed it.

VL
Vanguard Laboratory
Independent, ISO/IEC 17025 accredited
Certificate of Analysis
99.27 + 0.18%
Purity by HPLC
LotADA1026
Tested6/17/2026
Labeled10 mg
Measured9.94 mg
ISO 17025 Accredited 8× Tested
View signed certificate
Full QC Panel ✓ 2 passed
Chromatographic Purity
99.27% + 0.18%
Assay
9.94 mg
Arsenic (As)
LOQ 0.01 ppm (ICP-MS)
ND
Cadmium (Cd)
LOQ 0.01 ppm (ICP-MS)
ND
Lead (Pb)
LOQ 0.01 ppm (ICP-MS)
ND
Mercury (Hg)
LOQ 0.005 ppm (ICP-MS)
ND
Endotoxins
LAL
Pass - ≤ 5.00 EU/mg
PASS
Sterility
USP 71
Pass - No Growth Detected
PASS

ADAMAX — 10mg

Advanced Semax-Derivative for Neurobiological Research

ADAMAX is a research-market peptide described as a modified Semax-family analog incorporating an adamantane-related structural modification. It has attracted interest in experimental research surrounding cognitive signaling, neuroplasticity, neurotrophic pathways, and peptide stability.

Importantly, ADAMAX is a relatively novel and poorly characterized compound. Unlike Semax, which has a published research history, there is currently no substantial peer-reviewed human literature specifically establishing the pharmacology, safety, or efficacy of ADAMAX itself. Claims about improved stability or brain penetration remain theoretical and should not be presented as established clinical effects.

Research Areas

Because ADAMAX is structurally related to the Semax family, research interest centers around:

  • Cognitive and behavioral signaling
  • Neuroplasticity
  • Neurotrophic pathways
  • BDNF/TrkB-related research
  • Neuroprotection
  • Peptide stability and structure-function relationships
  • Blood-brain-barrier research

The Research Concept

The interest in ADAMAX comes from the hypothesis that structural modification of a Semax-related molecule may alter its stability, molecular behavior, and interaction with neurological pathways.

Structural Modification → Peptide Stability → Neurobiological Signaling → Cognitive & Neuroplasticity Research

However, these mechanisms have not been adequately demonstrated in controlled studies of ADAMAX itself. Research findings from Semax should therefore not automatically be attributed to ADAMAX.

ADAMAX vs. Semax

Semax has a considerably larger body of published research, including human investigations.

ADAMAX is a distinct experimental compound with substantially less characterization. Its appeal within research is primarily its modified molecular structure and the opportunity to investigate how those modifications may influence the properties of a Semax-related peptide.

For researchers interested in next-generation neuropeptide analogs, ADAMAX provides an interesting platform for comparative structure-activity and neurobiological research.

Research Use Only

This product is supplied for laboratory and research purposes only. ADAMAX is not FDA-approved and is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease or medical condition.

Stack Science™
Performance. Recovery. Longevity.

For Research Use Only. Not for human consumption.